| SEMERAD, Lukas, Zuzana SUSTKOVA, Petr CETKOVSKY, Pavel JINDRA, Zdenek KORISTEK, Jan NOVAK, Zdenek RACIL, Tomas SZOTKOWSKI, Barbora WEINBERGEROVA, Pavel ZAK, Zdeněk POSPÍŠIL, Jana BARANOVA and Jiri MAYER. The impact of centralised care of younger AML patients on treatment results: a retrospective analysis of real-world data from a national population-based registry. Acta Oncologica. Taylor and Francis Ltd., 2021, vol. 60, No 6, p. 818-823. ISSN 0284-186X. Available from: https://dx.doi.org/10.1080/0284186X.2021.1917002. |
Other formats:
BibTeX
LaTeX
RIS
@article{1821621,
author = {Semerad, Lukas and Sustkova, Zuzana and Cetkovsky, Petr and Jindra, Pavel and Koristek, Zdenek and Novak, Jan and Racil, Zdenek and Szotkowski, Tomas and Weinbergerova, Barbora and Zak, Pavel and Pospíšil, Zdeněk and Baranova, Jana and Mayer, Jiri},
article_number = {6},
doi = {http://dx.doi.org/10.1080/0284186X.2021.1917002},
keywords = {ACUTE MYELOID-LEUKEMIA; STEM-CELL TRANSPLANTATION; HOSPITAL VOLUME; MORTALITY; CHEMOTHERAPY; OUTCOMES},
language = {eng},
issn = {0284-186X},
journal = {Acta Oncologica},
title = {The impact of centralised care of younger AML patients on treatment results: a retrospective analysis of real-world data from a national population-based registry},
url = {https://www.tandfonline.com/doi/full/10.1080/0284186X.2021.1917002},
volume = {60},
year = {2021}
}
TY - JOUR
ID - 1821621
AU - Semerad, Lukas - Sustkova, Zuzana - Cetkovsky, Petr - Jindra, Pavel - Koristek, Zdenek - Novak, Jan - Racil, Zdenek - Szotkowski, Tomas - Weinbergerova, Barbora - Zak, Pavel - Pospíšil, Zdeněk - Baranova, Jana - Mayer, Jiri
PY - 2021
TI - The impact of centralised care of younger AML patients on treatment results: a retrospective analysis of real-world data from a national population-based registry
JF - Acta Oncologica
VL - 60
IS - 6
SP - 818-823
EP - 818-823
PB - Taylor and Francis Ltd.
SN - 0284186X
KW - ACUTE MYELOID-LEUKEMIA
KW - STEM-CELL TRANSPLANTATION
KW - HOSPITAL VOLUME
KW - MORTALITY
KW - CHEMOTHERAPY
KW - OUTCOMES
UR - https://www.tandfonline.com/doi/full/10.1080/0284186X.2021.1917002
N2 - The care for younger patients with acute myeloid leukaemia (AML) requires fully equipped medical facilities that have routine experience with the management of this aggressive disorder. Two independent analyses of real-world data from the United States (US) have showed a lower early mortality after an intensive chemotherapy when the patients are treated in high-volume centres or in National Cancer Institution-Designated Cancer Centres (NCI-CC) compared to the treatment in low-volume or in non-NCI-CC centres [1,2].
ER -
SEMERAD, Lukas, Zuzana SUSTKOVA, Petr CETKOVSKY, Pavel JINDRA, Zdenek KORISTEK, Jan NOVAK, Zdenek RACIL, Tomas SZOTKOWSKI, Barbora WEINBERGEROVA, Pavel ZAK, Zdeněk POSPÍŠIL, Jana BARANOVA and Jiri MAYER. The impact of centralised care of younger AML patients on treatment results: a retrospective analysis of real-world data from a national population-based registry. \textit{Acta Oncologica}. Taylor and Francis Ltd., 2021, vol.~60, No~6, p.~818-823. ISSN~0284-186X. Available from: https://dx.doi.org/10.1080/0284186X.2021.1917002.
|
